Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;99(4):1024-1047.
doi: 10.1002/jnr.24776. Epub 2020 Dec 28.

Understanding the glioblastoma tumor biology to optimize photodynamic therapy: From molecular to cellular events

Luis Exequiel Ibarra  1   2 , María Laura Vilchez  1   2 , Matías Daniel Caverzán  2 , Laura Natalia Milla Sanabria  1   2
Affiliations
Review

Understanding the glioblastoma tumor biology to optimize photodynamic therapy: From molecular to cellular events

Luis Exequiel Ibarra et al. J Neurosci Res. 2021 Apr.

Abstract

Photodynamic therapy (PDT) has recently gained attention as an alternative treatment of malignant gliomas. Glioblastoma (GBM) is the most prevalent within tumors of the central nervous system (CNS). Conventional treatments for this CNS tumor include surgery, radiation, and chemotherapy. Surgery is still being considered as the treatment of choice. Even so, the poor prognosis and/or recurrence of the disease after applying any of these treatments highlight the urgency of exploring new therapies and/or improving existing ones to achieve the definitive eradication of tumor masses and remaining cells. PDT is a therapeutic modality that involves the destruction of tumor cells by reactive oxygen species induced by light, which were previously treated with a photosensitizing agent. However, in recent years, its experimental application has expanded to other effects that could improve overall performance against GBM. In the current review, we revisit the main advances of PDT for GBM management and also, the recent mechanistic insights about cellular and molecular aspects related to tumoral resistance to PDT of GBM.

Keywords: blood-brain barrier; glioblastoma; photodynamic therapy; resistance mechanisms; tumor microenvironment.

PubMed Disclaimer

References

REFERENCES

    1. Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006). Astrocyte-endothelial interactions at the blood-brain barrier. Nature Reviews Neuroscience, 7, 41-53. https://doi.org/10.1038/nrn1824
    1. Abdala-Valencia, H., & Cook-Mills, J. M. (2006). VCAM-1 signals activate endothelial cell protein kinase Cα via oxidation. Journal of Immunology, 177, 6379-6387. https://doi.org/10.4049/jimmunol.177.9.6379
    1. Abdel Gaber, S. A., Müller, P., Zimmermann, W., Hüttenberger, D., Wittig, R., Abdel Kader, M. H., & Stepp, H. (2018). ABCG2-mediated suppression of chlorin e6 accumulation and photodynamic therapy efficiency in glioblastoma cell lines can be reversed by KO143. Journal of Photochemistry and Photobiology B: Biology, 178, 182-191. https://doi.org/10.1016/j.jphotobiol.2017.10.035
    1. Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., Korbelik, M., Moan, J., Mroz, P., Nowis, D., Piette, J., Wilson, B. C., & Golab, J. (2011). Photodynamic therapy of cancer: An update. CA: A Cancer Journal for Clinicians, 61, 250-281. https://doi.org/10.3322/caac.20114
    1. Akimoto, J. (2016). Photodynamic therapy for malignant brain tumors. Neurologia Medico-Chirurgica, 56, 151-157. https://doi.org/10.2176/nmc.ra.2015-0296

Publication types

Substances

LinkOut - more resources